Migration-associated secretion of melanoma inhibitory activity at the cell rear is supported by KCa3.1 potassium channels

Cell Research

Volumn 20, Issue 11, 2010, Pages 1224-1238

  Schmidt, Jennifer ^a   Friebel, Kristin ^b   Schönherr, Roland ^b   Coppolino, Marc G ^c   Bosserhoff, Anja Katrin ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CALCIUM; COAT PROTEIN COMPLEX I; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; KCNN4 PROTEIN, HUMAN; MIA PROTEIN, HUMAN; PYRAZOLE DERIVATIVE; SCLEROPROTEIN; TRAM 34; TUMOR PROTEIN;

ARTICLE; CELL MOTION; DRUG ANTAGONISM; HUMAN; MELANOMA; METABOLISM;

ACTINS; CALCIUM; CELL MOVEMENT; COAT PROTEIN COMPLEX I; EXTRACELLULAR MATRIX PROTEINS; HUMANS; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MELANOMA; NEOPLASM PROTEINS; PYRAZOLES;

EID: 78049463972     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2010.121     Document Type: Article

References (72)

1. Bosserhoff AK, Kaufmann M, Kaluza B, et al. Melanomainhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res 1997;57:3149-3153.
2. Bosserhoff AK, Stoll R, Sleeman JP, et al. Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity. Lab Invest 2003;83:1583-1594.
3. Poser I, Tatzel J, Kuphal S, Bosserhoff AK. Functional role of MIA in melanocytes and early development of melanoma. Oncogene 2004;23:6115-6124.
4. Bosserhoff AK, Lederer M, Kaufmann M, et al. MIA, a novel serum marker for progression of malignant melanoma. Anticancer Res 1999;19:2691-2693.
5. Dreau D, Bosserhoff AK, White RL, Buettner R, Holder WD. Melanoma-inhibitory activity protein concentrations in blood of melanoma patients treated with immunotherapy. Oncol Res 1999;11:55-61.
6. Stahlecker J, Gauger A, Bosserhoff A, et al. MIA as a reliable tumor marker in the serum of patients with malignant melanoma. Anticancer Res 2000;20:5041-5044.
7. Bauer R, Humphries M, Fassler R, et al. Regulation of integrin activity by MIA. J Biol Chem 2006;281:11669-11677.
8. Schmidt J, Bosserhoff AK. Processing of MIA protein during melanoma cell migration. Int J Cancer 2009.
9. Blesch A, Bosserhoff AK, Apfel R, et al. Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res 1994;54:5695-5701.
10. Rabouille C, Klumperman J. Opinion: the maturing role of COPI vesicles in intra-Golgi transport. Nat Rev Mol Cell Biol 2005;6:812-817.
11. Jena BP. Membrane fusion: role of SNAREs and calcium. Protein Pept Lett 2009;16:712-717.
12. Komuro H, Kumada T. Ca2+ transients control CNS neuronal migration. Cell Calcium 2005;37:387-393.
13. Pettit EJ, Fay FS. Cytosolic free calcium and the cytoskeleton in the control of leukocyte chemotaxis. Physiol Rev 1998;78:949-967.
14. Brundage RA, Fogarty KE, Tuft RA, Fay FS. Calcium gradients underlying polarization and chemotaxis of eosinophils. Science 1991;254:703-706.
15. Hahn K, DeBiasio R, Taylor DL. Patterns of elevated free calcium and calmodulin activation in living cells. Nature 1992;359:736-738.
16. Schwab A, Wojnowski L, Gabriel K, Oberleithner H. Oscillating activity of a Ca (2+)-sensitive K+ channel. A prerequisite for migration of transformed Madin-Darby canine kidney focus cells. J Clin Invest 1994;93:1631-1636.
17. Franco SJ, Huttenlocher A. Regulating cell migration: calpains make the cut. J Cell Sci 2005;118:3829-3838.
18. Jager H, Dreker T, Buck A, et al. Blockage of intermediateconductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol 2004;65:630-638.
19. Tajima N, Schonherr K, Niedling S, et al. Ca2+-activated K+ channels in human melanoma cells are up-regulated by hypoxia involving hypoxia-inducible factor-1alpha and the von Hippel-Lindau protein. J Physiol 2006;571:349-359.
20. Wang J, Xu YQ, Liang YY, et al. An intermediate-conductance Ca (2+)-activated K (+) channel mediates B lymphoma cell cycle progression induced by serum. Pfugers Arch 2007;454:945-956.
21. Lallet-Daher H, Roudbaraki M, Bavencoffe A, et al. Intermediate- conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry. Oncogene 2009;28:1792-1806.
22. Schwab A, Gabriel K, Finsterwalder F, et al. Polarized ion transport during migration of transformed Madin-Darby canine kidney cells. Pfugers Arch 1995;430:802-807.
23. Schwab A, Reinhardt J, Schneider SW, Gassner B, Schuricht B. K (+) channel-dependent migration of fbroblasts and human melanoma cells. Cell Physiol Biochem 1999;9:126-132.
24. Cruse G, Duffy SM, Brightling CE, Bradding P. Functional KCa3.1 K+ channels are required for human lung mast cell migration. Thorax 2006;61:880-885.
25. Kessler W, Budde T, Gekle M, Fabian A, Schwab A. Activation of cell migration with fbroblast growth factor-2 requires calcium-sensitive potassium channels. Pflugers Arch 2008;456:813-823.
26. Palazzo AF, Joseph HL, Chen YJ, et al. Cdc42, dynein, and dynactin regulate MTOC reorientation independent of Rhoregulated microtubule stabilization. Curr Biol 2001;11:1536-1541.
27. Nebenfuhr A, Ritzenthaler C, Robinson DG. Brefeldin A: deciphering an enigmatic inhibitor of secretion. Plant Physiol 2002;130:1102-1108.
28. Iida J, Wilhelmson KL, Price MA, et al. Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth. J Invest Dermatol 2004;122:167-176.
29. Mori H, Tomari T, Koshikawa N, et al. CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J 2002;21:3949-3959.
30. Nugent MA, Iozzo RV. Fibroblast growth factor-2. Int J Biochem Cell Biol 2000;32:115-120.
31. Nickel W. Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffc 2005;6:607-614.
32. Aridor M, Bannykh SI, Rowe T, Balch WE. Sequential coupling between COPII and COPI vesicle coats in endoplasmic reticulum to Golgi transport. J Cell Biol 1995;131:875-893.
33. Barlowe C, Orci L, Yeung T, et al. COPII: a membrane coat formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum. Cell 1994;77:895-907.
34. Kuge O, Kuge S. [COP-coated vesicles in intracellular protein transport]. Tanpakushitsu Kakusan Koso 1995;40:2427-2435.
35. Gaynor EC, Graham TR, Emr SD. COPI in ER/Golgi and intra-Golgi transport: do yeast COPI mutants point the way? Biochim Biophys Acta 1998;1404:33-51.
36. Hachiya NS, Watanabe K, Yamada M, Sakasegawa Y, Kaneko K. Anterograde and retrograde intracellular traffcking of fuorescent cellular prion protein. Biochem Biophys Res Commun 2004;315:802-807.
37. Schwab A. Function and spatial distribution of ion channels and transporters in cell migration. Am J Physiol Renal Physiol 2001;280: F739-F747.
38. Ghanshani S, Wulff H, Miller MJ, et al. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem 2000;275:37137-37149.
39. Barfod ET, Moore AL, Roe MW, Lidofsky SD. Ca2+-activated IK1 channels associate with lipid rafts upon cell swelling and mediate volume recovery. J Biol Chem 2007;282:8984-8993.
40. Strayer DS, Hoek JB, Thomas AP, White MK. Cellular activation by Ca2+ release from stores in the endoplasmic reticulum but not by increased free Ca2+ in the cytosol. Biochem J 1999;44 Pt 1:39-46.
41. Kauffman RF, Taylor RW, Pfeiffer DR. Cation transport and specifcity of ionomycin. Comparison with ionophore A23187 in rat liver mitochondria. J Biol Chem 1980;255:2735-2739.
42. Ridley AJ, Schwartz MA, Burridge K, et al. Cell migration: integrating signals from front to back. Science 2003;302:1704-1709.
43. Vicente-Manzanares M, Webb DJ, Horwitz AR. Cell migration at a glance. J Cell Sci 2005;118:4917-4919.
44. Borregaard N, Lollike K, Kjeldsen L, et al. Human neutrophil granules and secretory vesicles. Eur J Haematol 1993;51:187-198.
45. Jamur MC, Vugman I, Hand AR. Ultrastructural and cytochemical studies of acid phosphatase and trimetaphosphatase in rat peritoneal mast cells developing in vivo. Cell Tissue Res 1986;244:557-563.
46. Burkhardt JK, Hester S, Lapham CK, Argon Y. The lytic granules of natural killer cells are dual-function organelles combining secretory and pre-lysosomal compartments. J Cell Biol 1990;111:2327-2340.
47. Peters PJ, Borst J, Oorschot V, et al. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 1991;173:1099-1109.
48. Bennett MK. Ca2+ and the regulation of neurotransmitter secretion. Curr Opin Neurobiol 1997;7:316-322.
49. Greengard P, Valtorta F, Czernik AJ, Benfenati F. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 1993;259:780-785.
50. Kato M, Sasaki T, Ohya T, et al. Physical and functional interaction of rabphilin-3A with alpha-actinin. J Biol Chem 1996;271:31775-31778.
51. Miyazaki M, Shirataki H, Kohno H, et al. Identification as beta-adducin of a protein interacting with rabphilin-3A in the presence of Ca2+ and phosphatidylserine. Biochem Biophys Res Commun 1994;205:460-466.
52. Weis S, Schneggenburger R, Neher E. Properties of a model of Ca (++)-dependent vesicle pool dynamics and short term synaptic depression. Biophys J 1999;77:2418-2429.
53. Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS. Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature 2005;434:786-792.
54. Stock C, Schwab A. Role of the Na/H exchanger NHE1 in cell migration. Acta Physiol (Oxf) 2006;187:149-157.
55. Lawson MA, Maxfield FR. Ca (2+) - and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature 1995;377:75-79.
56. Yang S, Huang XY. Ca2+ infux through L-type Ca2+ channels controls the trailing tail contraction in growth factorinduced fibroblast cell migration. J Biol Chem 2005;280:27130-27137.
57. Meyer R, Schonherr R, Gavrilova-Ruch O, Wohlrab W, Heinemann SH. Identifcation of ether a go-go and calcium-activated potassium channels in human melanoma cells. J Membr Biol 1999;171:107-115.
58. Aiyar J. Potassium channels in leukocytes and toxins that block them: structure, function and therapeutic implications. Pererspect Drug Discov Des 1999;15/16:257-280.
59. Eder C. Ion channels in microglia (brain macrophages). Am J Physiol 1998;275: C327-C342.
60. Kohler R, Wulff H, Eichler I, et al. Blockade of the intermediate- conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation 2003;108:1119-1125.
61. Ouadid-Ahidouch H, Roudbaraki M, Delcourt P, et al. Functional and molecular identification of intermediate-conductance Ca (2+)-activated K (+) channels in breast cancer cells: association with cell cycle progression. Am J Physiol Cell Physiol 2004;287: C125-C134.
62. Parihar AS, Coghlan MJ, Gopalakrishnan M, Shieh CC. Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation. Eur J Pharmacol 2003;471:157-164.
63. Schwab A, Westphale HJ, Wojnowski L, Wunsch S, Oberleithner H. Spontaneously oscillating K+ channel activity in transformed Madin-Darby canine kidney cells. J Clin Invest 1993;92:218-223.
64. Jin M, Defoe DM, Wondergem R. Hepatocyte growth factor/scatter factor stimulates Ca2+-activated membrane K+ current and migration of MDCK II cells. J Membr Biol 2003;191:77-86.
65. Schilling T, Stock C, Schwab A, Eder C. Functional importance of Ca2+-activated K+ channels for lysophosphatidic acid-induced microglial migration. Eur J Neurosci 2004;19:1469-1474.
66. Schwab A, Wulf A, Schulz C, et al. Subcellular distribution of calcium-sensitive potassium channels (IK1) in migrating cells. J Cell Physiol 2006;206:86-94.
67. Schwab A, Schuricht B, Seeger P, Reinhardt J, Dartsch PC. Migration of transformed renal epithelial cells is regulated by K+ channel modulation of actin cytoskeleton and cell volume. Pfugers Arch 1999;438:330-337.
68. Rao JN, Platoshyn O, Li L, et al. Activation of K (+) channels and increased migration of differentiated intestinal epithelial cells after wounding. Am J Physiol Cell Physiol 2002;282: C885-C898.
69. Feinshreiber L, Singer-Lahat D, Ashery U, Lotan I. Voltagegated potassium channel as a facilitator of exocytosis. Ann N Y Acad Sci 2009;1152:87-92.
70. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989;77:51-59.
71. Tatzel J, Poser I, Schroeder J, Bosserhoff AK. Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes. Pigment Cell Res 2005;18:92-101.
72. Neher E. The use of fura-2 for estimating Ca buffers and Ca fuxes. Neuropharmacology 1995;34:1423-1442.